1. |
胥月晴, 孔雕, 彭伟, 等. 《外科随机对照试验的统计与方法指南》解读(一): 基于JAMASurgery的报道. 中国普外基础与临床杂志, [2024-12-09]. http: //kns. cnki. net/kcms/detail/51. 1505. R. 20241121. 1542. 032. html.
|
2. |
Kougias P, Kaji AH, Boermeester M. Practical guide to designing a clinical trial in surgery. JAMA Surg, 2022, 157(12): 1152-1153.
|
3. |
Dijkgraaf MGW, Haukoos J, Itani KMF. Practical guide to design choice of randomized clinical trials in surgery. JAMA Surg, 2022, 157(12): 1154-1155.
|
4. |
Newman LA, Schwartz TA, Boermeester M. Practical guide to recruitment of participants for surgical clinical trials. JAMA Surg, 2022, 157(12): 1156-1157.
|
5. |
de Jonge SW, Kaji AH, Itani KMF. Practical guide to statistical considerations in clinical trials in surgery. JAMA Surg, 2023, 158(1): 89-90.
|
6. |
Kim LT, Kaji AH, Salminen P. Practical guide to quality control in surgical trials. JAMA Surg, 2023, 158(1): 91-92.
|
7. |
Fleshman J, Haukoos J, Salminen P. Practical guide to surgical clinical trial implementation, oversight, and regulatory aspects. JAMA Surg, 2023, 158(1): 93-94.
|
8. |
Fong Y, Haukoos J, Zuckerbraun BS. Practical guide to adjuncts to clinical trials in surgery. JAMA Surg, 2023, 158(1): 95-96.
|
9. |
Pawlik TM, Schwartz TA, Itani KMF. Practical guide to ethical considerations in clinical trials in surgery. JAMA Surg, 2023, 158(2): 204-205.
|
10. |
Lazar EL, Schwartz TA, Zuckerbraun BS. Practical guide to budgeting and funding a clinical trial in surgery. JAMA Surg, 2023, 158(2): 206-207.
|
11. |
Winter DC, Haukoos J, Salminen P. Practical guide to clinical trial publication. JAMA Surg, 2023, 158(2): 208-209.
|
12. |
Huang H, Hou Y, Fang H, et al. Unveiling quality of clinical trial in China: from concern to confirmation. Cancer Commun (Lond), 2024, 44(5): 576-579.
|
13. |
Huang GD, Bull J, Johnston McKee K, et al. Clinical trials recruitment planning: a proposed framework from the Clinical Trials Transformation Initiative. Contemp Clin Trials, 2018, 66: 74-79.
|
14. |
Newman LA, Lee CT, Parekh LP, et al. Use of the National Cancer Data Base to develop clinical trials accrual targets that are appropriate for minority ethnicity patients: a report from the American College of Surgeons Oncology Group (ACOSOG) Special Population Committee. Cancer, 2006, 106(1): 188-195.
|
15. |
Stunkel L, Grady C. More than the money: a review of the literature examining healthy volunteer motivations. Contemp Clin Trials, 2011, 32(3): 342-352.
|
16. |
Wang Z, Chen G, Liu X, et al. The motivations, barriers, and sociodemographic characteristics of healthy Chinese volunteers in phase I research. Eur J Clin Pharmacol, 2021, 77(4): 557-568.
|
17. |
梁梦音, 梁嘉恩, 张恩恩, 等. 国内临床试验参与意愿分析及招募启示. 全科护理, 2024, 22(3): 435-438.
|
18. |
Ioannidis JP. Why most published research findings are false. PLoS Med, 2005, 2(8): e124.
|
19. |
Gamble C, Krishan A, Stocken D, et al. Guidelines for the content of statistical analysis plans in Clinical trials. JAMA, 2017, 318(23): 2337-2343.
|
20. |
Chan AW, Tetzlaff JM, Gøtzsche PC, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ, 2013, 346: e7586.
|
21. |
杨丽虹, 刘少南, 吴大嵘, 等. 最小临床意义差值的概念及其估算方法. 中国循证医学杂志, 2020, 20(11): 1345-1352.
|
22. |
Noordzij M, Tripepi G, Dekker FW, et al. Sample size calculations: basic principles and common pitfalls. Nephrol Dial Transplant, 2010, 25(5): 1388-1393.
|
23. |
Brookes ST, Whitley E, Peters TJ, et al. Subgroup analyses in randomised controlled trials: quantifying the risks of false-positives and false-negatives. Health Technol Assess, 2001, 5(33): 1-56.
|
24. |
Moher D, Hopewell S, Schulz KF, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ, 2010, 340: c869.
|
25. |
Hernán MA, Robins JM. Per-protocol analyses of pragmatic trials. N Engl J Med, 2017, 377(14): 1391-1398.
|
26. |
熊中敏, 郭怀宇, 吴月欣. 缺失数据处理方法研究综述. 计算机工程与应用, 2021, 57(14): 27-38.
|
27. |
Little RJ, D’Agostino R, Cohen ML, et al. The prevention and treatment of missing data in clinical trials. N Engl J Med, 2012, 367(14): 1355-1360.
|
28. |
McIsaac DI, MacDonald DB, Aucoin SD. Frailty for perioperative clinicians: a narrative review. Anesth Analg, 2020, 130(6): 1450-1460.
|
29. |
Stadler ZK, Come SE. Review of gene-expression profiling and its clinical use in breast cancer. Crit Rev Oncol Hematol, 2009, 69(1): 1-11.
|
30. |
Ignatiadis M, Sledge GW, Jeffrey SS. Liquid biopsy enters the clinic - implementation issues and future challenges. Nat Rev Clin Oncol, 2021, 18(5): 297-312.
|
31. |
Eagleson R, Altamirano-Diaz L, McInnis A, et al. Implementation of clinical research trials using web-based and mobile devices: challenges and solutions. BMC Med Res Methodol, 2017, 17(1): 43.
|
32. |
赵纪春, 曾国军, 王家嵘. 人工智能在血管外科的应用前景. 中国普外基础与临床杂志, 2018, 25(5): 515-518.
|
33. |
Vijayan V, Connolly JP, Condell J, et al. Review of wearable devices and data collection considerations for connected health. Sensors (Basel), 2021, 21(16): 5589.
|
34. |
Julien HM, Eberly LA, Adusumalli S. Telemedicine and the forgotten America. Circulation, 2020, 142(4): 312-314.
|
35. |
张群华. 拥抱互联网医疗和人工智能融合的高光时刻. 中国普外基础与临床杂志, 2020, 27(9): 1049-1051.
|
36. |
Chan AW, Tetzlaff JM, Altman DG, et al. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med, 2013, 158(3): 200-207.
|
37. |
Schulz KF, Altman DG, Moher D, et al. CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann Intern Med, 2010, 152(11): 726-732.
|
38. |
Piaggio G, Elbourne DR, Pocock SJ, et al. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement. JAMA, 2012, 308(24): 2594-2604.
|
39. |
Campbell MK, Piaggio G, Elbourne DR, et al. Consort 2010 statement: extension to cluster randomised trials. BMJ, 2012, 345: e5661.
|